Inicio・Lista de Acciones・Erasca Inc

Erasca Inc

Abierto

17.82 -1.44

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

13.72

Máximo

18.04

Métricas clave
By Trading Economics
Ingresos	-154M -183M
BPA	-0.6
Empleados	103
EBITDA	-151M -183M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+22.42% upside

Dividendos
By Acuity
Próximas Ganancias	10 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	3.3B 6.6B
Apertura anterior	19.26
Cierre anterior	17.82

Erasca Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 ago 2026, 23:51 UTC

Cautious Optimism Surrounds Upcoming South Korea Manufacturing PMI Release Amid Mixed Economic Signals and Regional Trends

2 ago 2026, 23:51 UTC

Japan's Upcoming Current Account Release on August 9, 2026, Expected to Reflect Export-Import Balance Amidst Cautiously Optimistic Market Sentiment.

2 ago 2026, 23:51 UTC

Correlated Moves

Macro News

Bitcoin is trading higher, influenced by rising crude oil prices and positive tech stock performance. Ethereum's increase also supports Bitcoin's upward movement today.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility and geopolitical tensions, as investors brace for potential Fed rate hikes and key economic data releases.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility, while momentum trading strategies face significant drawdowns as the Fed's steady interest rates and geopolitical tensions influence investor sentiment.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid geopolitical tensions and potential U.S. rate hikes, as investors brace for key labor market data.

2 ago 2026, 23:31 UTC

Bitcoin and Ethereum rise amid declining momentum trading strategies, while geopolitical tensions and inflation concerns heighten expectations for a potential Federal Reserve interest rate hike.

2 ago 2026, 23:21 UTC

Social Media

Correlated Moves

Macro News

Geopolitical tensions and rising fuel prices are driving demand for gold. Gold has gained modestly since Friday, with silver also rising today.

2 ago 2026, 23:02 UTC

Correlated Moves

AUD/CAD is higher in after-market trading, reflecting a modest gain since Friday's close and correlating with a rise in AUD/USD.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/JPY is advancing during Sunday’s session, supported by rising gold prices. The pair remains below its 20-day moving average amid ongoing market volatility.

2 ago 2026, 23:01 UTC

Correlated Moves

Macro News

EUR/USD rises in after-market trading, reflecting market reactions to potential U.S. monetary policy changes and concerns about a financial crisis linked to AI developments.

2 ago 2026, 23:01 UTC

Copper is trading higher during Sunday’s session, maintaining strength despite a slight pullback from earlier gains. It remains above its 20-day moving average.

2 ago 2026, 23:01 UTC

GBP/NOK is trading higher in after-market hours, reflecting a shift in trading dynamics despite recent market volatility and being near the lower end of its one-month range.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver prices are advancing today, reflecting a broader upward movement in precious metals, despite earlier intraday volatility. Gold's increase may support silver's rise.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/NZD is higher today, recovering from an earlier low and reflecting a similar rise in gold prices since Friday's close.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/CHF is trading higher, recovering from earlier lows and reflecting a strong upward trajectory since Friday's close, in line with rising gold prices.

2 ago 2026, 23:01 UTC

Macro News

The Nikkei 225 Index is lower in after-market hours, continuing a decline linked to a weaker yen and potential interest rate hikes amid inflation concerns.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/GBP is trading higher, recovering from an earlier dip. The asset has increased notably since Friday's close, reflecting a strong correlation with gold.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/CAD is trading higher, rebounding from earlier losses amid rising silver prices. Broader market sentiment shows a decline in momentum trading strategies.

2 ago 2026, 23:01 UTC

Correlated Moves

The S&P 500 Index is trading higher, continuing a trend of three consecutive positive sessions, supported by gains in the Dow Jones Index.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/JPY is trading higher amid market volatility, reflecting a notable increase. The rise aligns with a gain in gold, indicating a strong correlation.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/SGD is trading higher, reflecting a broader rise in precious metals. Earlier, the asset pulled back but has since rebounded from session lows.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/AUD is rising today, supported by an increase in Gold (XAU/USD). The price remains near the lower end of its one-month trading range.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/CHF is advancing, reflecting gains in Gold (XAU/USD) and macroeconomic factors. Recent market volatility continues to influence investor risk sentiment.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/GBP is trading higher, recovering from an earlier dip amid increased Gold prices and shifts in investor sentiment during market volatility.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/NZD is trading higher, recovering from earlier fluctuations, as gold prices rise. It remains about 1.03% below its 20-day moving average.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver/HKD is trading higher today, supported by a rise in gold prices. Earlier, it experienced notable volatility but has since recovered above Friday's close.

2 ago 2026, 23:01 UTC

Macro News

The US 5Y Treasury Bond Index is higher, recovering from an early dip amid Federal Reserve discussions on interest rate hikes and inflation concerns.

2 ago 2026, 23:01 UTC

Correlated Moves

Silver Ounce vs Euro shows notable gains today, driven by rising gold prices. Earlier, XAG/EUR pulled back from a session high but remains elevated.

2 ago 2026, 23:01 UTC

Correlated Moves

Gold/HKD is higher today, reflecting a modest gain since Friday's close amid broader market volatility and heightened investor anxiety.

Comparación entre iguales

Cambio de precio

Erasca Inc previsión

Precio Objetivo

By TipRanks

22.42% repunte

Estimación a 12 Meses

Media 22.22 USD 22.42%

Máximo 30 USD

Mínimo 18 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Erasca Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

Comprar

Mantener

Vender

De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Erasca Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.